Recent guidelines from the American College of Gastroenterology (ACG) and other major medical societies recommend universal testing for Lynch syndrome in patients diagnosed with colorectal cancer. However, the financial effect of testing is unclear.
A new study presented at the ACG’s 2016 annual meeting (poster P121) suggests that testing for the genetic syndrome costs about $450 per case of colorectal cancer. That figure is more than outweighed by the clinical value of screening, said